Management Sciences for Health
Published on Management Sciences for Health (https://www.msh.org)

Home > Resources > Publications

Results 1051 - 1075 of 1434

Community-based DOTS for improved TB case detection and treatment outcomes in Afghanistan [1]

[2]

CB DOTS is an approach for engaging communities to support detection and treatment of TB, while also bringing TB services closer to their communities. In Afghanistan, CB DOTS has been implemented in more than 715 health facilities and 15 provinces, and the national Ministry of Public Health is integrating the CB DOTS strategy into the nationwide basic package of health services.

Health Systems Strengthening and TB: A guide to MSH Events at the 2019 Union World Conference on Lung Health [3]

The 50th Union World Conference on Lung Health, October 30-November 3, brings together researchers, global advocates, scientists, healthcare professionals, students and community members working on all aspects of lung health. MSH staff will be participating in a variety of symposia, workshops, posters, and oral presentations to share our experience and expertise on a range of topics that

​​​Response to Anti-Tuberculosis Treatment by People over Age 60 in Kampala, Uganda [4]

While old age is a known risk factor for developing active tuberculosis (TB), studies on TB in the population aged 60 years and older (considered elderly in this study) are few, especially in the developing world. Results of the TB prevalence survey in Uganda found high TB prevalence (570/100,000) in people over 65. We focused on treatment outcomes in the elderly to understand this epidemic better. We conducted a retrospective analysis of data from TB facility registers in Kampala City for the period 2014-2015. We analyzed the 2014-15 cohort with respect to age, sex, disease class, patients' human immunodeficiency virus (HIV) and directly observed therapy (DOT) status, type of facility, and treatment outcomes and compared findings in the elderly (≥60) and younger (<60) age groups. Of 15,429 records, 3.3% (514/15+,429) were for elderly patients. The treatment success rate (TSR) among elderly TB patients (68.3%) was lower than that of the non-elderly (80.9%) and the overall TSR 80.5%, (12,417/15,429) in Kampala. Although the elderly were less likely to test positive for HIV than the young, they had a two-fold higher risk of unfavorable treatment outcomes and were more likely to die while on treatment. However, there was no statistically significantly difference between treatment outcomes among HIV-positive and HIV-negative elderly TB patients. Compared to the younger TB patients, elderly TB patients have markedly poorer treatment outcomes, although TB/HIV co-infection rates in this age group are lower.

Knowledge, Attitudes, and Practices Related to TB among the General Population of Ethiopia: Findings from a National Cross-Sectional Survey [5]

Ethiopia is among the high-burden countries for tuberculosis (TB), TB/HIV, and drug-resistant TB. The aim of this nationwide study was to better understand TB-related knowledge, attitudes, and practices (KAPs) and generate evidence for policy and decision-making. Of 3,503 participants, 884 (24.4%), 836 (24.1%), and 1,783 (51.5%) were TB patients, families of TB patients, and the general population, respectively. The mean age was 34.3 years, and 50% were women. Forty-six percent were heads of households, 32.1% were illiterate, 20.3% were farmers, and 19.8% were from the lowest quintile. The majority (95.5%) had heard about TB, but only 25.8% knew that TB is caused by bacteria. The majority (85.3%) knew that TB could be cured. Most Ethiopians have a high level of awareness about TB and seek care in public health facilities, and communities are generally supportive. Inadequate knowledge about TB transmission, limited engagement of community health workers, and low preference for using community health workers were the key challenges.

Request for proposals: trainings for health technology assessment implementers and users [6]

This request for proposals was cancelled. 

Understanding Job Satisfaction and Motivation among Nurses in Public Health Facilities of Ethiopia: A Cross-Sectional Study [7]

The objective of this study was to examine job satisfaction, motivation and associated factors among nurses working in the public health facilities of Ethiopia, with the aim of improving performance and productivity in the health care system. From a random sample of 125 health facilities, 424 nurses were randomly selected for face-to-face interviews in all regions of Ethiopia. Overall, 60.8% of nurses expressed satisfaction with their job. Job satisfaction levels were significantly higher for female nurses, those older than 29  years and those who had over 10  years of work experience. Satisfaction with remuneration, recognition, professional advancement, features of the work itself, and nurses’ work experiences from 5 to 10  years were significantly associated with overall job satisfaction after controlling for other predictors. The study findings are signals for the Ministry of Health to strengthen the human resource management system and practices to improve nurses’ overall job satisfaction and motivation, especially among nurses with 5 to 10  years of experience on the job. Expanded recognition systems and opportunities for advancement are required to increase nurses’ job satisfaction and motivation. Equitable salary and fringe benefits are also needed to reduce their dissatisfaction with the job.

Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End TB [8]

Tuberculosis (TB) elimination requires innovative approaches. The new Global Tuberculosis Network (GTN) aims to conduct research on key unmet therapeutic and diagnostic needs in the field of TB elimination using multidisciplinary, multisectorial approaches. The TB Pharmacology section within the new GTN aims to detect and study the current knowledge gaps, test potential solutions using human pharmacokinetics informed through preclinical infection systems, and return those findings to the bedside. Moreover, this approach would allow prospective identification and validation of optimal shorter therapeutic durations with new regimens. Optimized treatment using available and repurposed drugs may have an increased impact when prioritizing a person-centered approach and acknowledge the importance of age, gender, comorbidities, and both social and programmatic environments. In this viewpoint article, we present an in-depth discussion on how TB pharmacology and the related strategies will contribute to TB elimination.

Uptake and Correlates of HIV Testing among Men in Malawi: Evidence from a National Population-Based Household Survey [9]

The aim of this study was to assess the uptake and determinants of HIV testing among men in Malawi. Secondary data analysis was conducted on cross–sectional household data for 7478 men aged 15 to 54 years drawn from the 2015–16 Malawi Demographic and Health Survey. Secondary data analysis was conducted on cross–sectional household data for 7478 men aged 15 to 54 years drawn from the 2015–16 Malawi Demographic and Health Survey. Descriptive statistics, bivariate and multivariable logistic regression analyses were performed to identify the socio–demographic, behavioral and health service related factors that are associated with HIV testing service utilisation by men in Malawi. All analyses were performed using the complex sample analysis procedure of the Statistical Package for the Social Sciences version 22.0 to account for the multistage sampling used in Demographic Health Survey. Overall, 69.9% of the participants had ever been tested for HIV. The results indicate that age, region of residence, marital status, covered by health insurance, education and age at first sexual debut are significant predictors of HIV testing among men in Malawi. In particular, men who were in the age group 30–39 years, married, those with secondary or above education, and those who had health insurance were more likely to utilise HIV testing service than their counterparts. The findings suggest that HIV testing services and programmes need to target younger unmarried men aged 15–19 and men with low level or no education and expand HIV testing services to the central and southern regions of Malawi. 

Landscape Analysis of Verification and Serialization System in Ukraine [10]

[11]

In order to gain more in-depth understanding of the overall problem with substandard and falsified (SF) medical products and how other countries have combated the issue, USAID’s SAFEMed project carried out a landscape analysis that included a desktop review of policies and guidance on the subject matter coupled with interviews with relevant stakeholders in Ukraine to understand their perspec

SAFEMed Activity News Digest - October 2019 [12]

[13]

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, October 2019 edition. 

Introducing a New Strategy on Bioequivalence in Ukraine [14]

[15]

USAID's SAFEMed Bioequivalence Report provides an in-depth analysis of current and future legislative requirements for better governance of bioequivalence in Ukraine.

Landscape Review: Private Logistics and Distribution of Medicinal Products in Ukraine [16]

An exciting aspect of USAID SAFEMed's workstream in Ukraine is around medicines supply chains and logistics.

Appel à propositions IHSA-2019-002 [17]

Appel à propositions IHSA-2019-002 

Annexe A - Modèle de Narratif de Budget [18]

Annexe A - Modèle de Narratif de Budget

Annexe B - Modele de budget [19]

Annexe B - Modèle de budget 

Appel à propositions : Réalisation d’une enquête de couverture d’une campagne de chimio prévention du paludisme saisonnier au Bénin [20]

Le projet Integrated Health Services Activity (IHSA), financé par l’Agence des États-Unis pour le développement international (USAID) et mis en œuvre au Bénin, publie l’appel à propositions IHSA-2019-002.

SAFEMed Activity News Digest - November 2019 [21]

[22]

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, November 2019 edition. 

SAFEMed Activity News Digest - December 2019 [23]

[24]

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, December 2019 edition.

The Added Value of Combining LDP with Clinical Training on PPFP Service Delivery [25]

[26]

The USAID-funded Leadership, Management, and Governance and Evidence to Action Projects studied the effect of combining a leadership development program with clinical training to improve postpartum family planning services in Cameroon.The study took place at two hospitals in Yaoundé, Cameroon, from October 2014-September 2015, with data collected at baseline, midline, and endline stages.

Cameroon Study Research Brief [27]

[28]

This research brief highlights excerpts of findings from a study conducted by the USAID-funded Leadership, Management, and Governance and Evidence to Action Projects in Cameroon.The study took place at two hospitals in Yaoundé, Cameroon, from October 2014-September 2015, and studied the effect of combining a leadership development program with clinical training to improve postpartum family

Designing and Implementing a Highly Effective Youth Leadership Program [29]

[30]

This technical highlight explores the results of the USAID-funded Leadership, Management, and Governance Project's assessment of youth leadership development programs around the world and provides six recommendations for implementing an effective youth leadership program.

LMG/NMCP Project Final Report [31]

[32]

From 2013-2017, the USAID-funded Leadership, Management, and Governance (LMG) Project worked with the President's Malaria Initiative (PMI) to provide long-term technical assistance to the National Malaria Control Programs (NMCPs) of seven countries.The LMG/NMCP Project embedded Senior Technical Advisors within the NCMP, alongside NMCP staff, for two to four years.

Fighting Malaria with Skilled Leadership [33]

[34]

From 2013-2017, the LMG Project provided technical assistance to the National Malaria Control Programs (NMCPs) in Burundi, Cameroon, Côte d’Ivoire, Guinea, Lao PDR, Liberia, Sierra Leone, and Togo, through the indispensable work and expertise of Senior Technical Advisors.These advisors, who are directly embedded within the NMCP, served as technical experts as well as day-to-day coaches

The Added Value of Long-Term Technical Assistance to National Malaria Control Programs [35]

[36]

From 2013-2017, the USAID-funded Leadership, Management, and Governance (LMG) Project worked with the President's Malaria Initiative (PMI) to provide long-term technical assistance to the National Malaria Control Programs (NMCPs) of seven countries.The LMG/NMCP Project embedded Senior Technical Advisors within the NCMP, alongside NMCP staff, for two to four years.

Long-term Technical Assistance Advisors [37]

[38]

From 2013 to 2017, the USAID-funded Leadership, Management, and Governance (LMG) Project provided technical assistance to National Malaria Control Programs (NMCPs), through the placement of long-term technical advisors, in Burundi, Cameroon, Côte d’Ivoire, Guinea, Lao PDR, Liberia, and Sierra Leone.The LMG/NMCP Project's experience suggested that this technical assistance model couldbe

Pages

  • « first [39]
  • ‹ previous [40]
  • …
  • 39 [41]
  • 40 [42]
  • 41 [43]
  • 42 [40]
  • 43
  • 44 [44]
  • 45 [45]
  • 46 [46]
  • 47 [47]
  • …
  • next › [44]
  • last » [48]

Source URL: https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=42

Links
[1] https://www.msh.org/resources/community-based-dots-for-improved-tb-case-detection-and-treatment-outcomes-in-afghanistan?page=42
[2] https://www.msh.org/resources/community-based-dots-for-improved-tb-case-detection-and-treatment-outcomes-in-afghanistan
[3] https://www.msh.org/resources/health-systems-strengthening-and-tb-a-guide-to-msh-events-at-the-2019-union-world?page=42
[4] https://www.msh.org/resources/%E2%80%8B%E2%80%8B%E2%80%8Bresponse-to-anti-tuberculosis-treatment-by-people-over-age-60-in-kampala-uganda?page=42
[5] https://www.msh.org/resources/knowledge-attitudes-and-practices-related-to-tb-among-the-general-population-of-ethiopia?page=42
[6] https://www.msh.org/resources/request-for-proposals-trainings-for-health-technology-assessment-implementers-and-users?page=42
[7] https://www.msh.org/resources/understanding-job-satisfaction-and-motivation-among-nurses-in-public-health-facilities-of?page=42
[8] https://www.msh.org/resources/integrating-pharmacokinetics-and-pharmacodynamics-in-operational-research-to-end-tb?page=42
[9] https://www.msh.org/resources/uptake-and-correlates-of-hiv-testing-among-men-in-malawi-evidence-from-a-national-0?page=42
[10] https://www.msh.org/resources/landscape-analysis-of-verification-and-serialization-system-in-ukraine?page=42
[11] https://www.msh.org/resources/landscape-analysis-of-verification-and-serialization-system-in-ukraine
[12] https://www.msh.org/resources/safemed-activity-news-digest-october-2019?page=42
[13] https://www.msh.org/resources/safemed-activity-news-digest-october-2019
[14] https://www.msh.org/resources/introducing-a-new-strategy-on-bioequivalence-in-ukraine?page=42
[15] https://www.msh.org/resources/introducing-a-new-strategy-on-bioequivalence-in-ukraine
[16] https://www.msh.org/resources/landscape-review-private-logistics-and-distribution-of-medicinal-products-in-ukraine?page=42
[17] https://www.msh.org/resources/appel-%C3%A0-propositions-ihsa-2019-002?page=42
[18] https://www.msh.org/resources/annexe-a-mod%C3%A8le-de-narratif-de-budget?page=42
[19] https://www.msh.org/resources/annexe-b-modele-de-budget?page=42
[20] https://www.msh.org/resources/appel-%C3%A0-propositions-r%C3%A9alisation-d%E2%80%99une-enqu%C3%AAte-de-couverture-d%E2%80%99une-campagne-de-chimio?page=42
[21] https://www.msh.org/resources/safemed-activity-news-digest-november-2019?page=42
[22] https://www.msh.org/resources/safemed-activity-news-digest-november-2019
[23] https://www.msh.org/resources/safemed-activity-news-digest-december-2019?page=42
[24] https://www.msh.org/resources/safemed-activity-news-digest-december-2019
[25] https://www.msh.org/resources/the-added-value-of-combining-ldp-with-clinical-training-on-ppfp-service-delivery?page=42
[26] https://www.msh.org/resources/the-added-value-of-combining-ldp-with-clinical-training-on-ppfp-service-delivery
[27] https://www.msh.org/resources/cameroon-study-research-brief?page=42
[28] https://www.msh.org/resources/cameroon-study-research-brief
[29] https://www.msh.org/resources/designing-and-implementing-a-highly-effective-youth-leadership-program?page=42
[30] https://www.msh.org/resources/designing-and-implementing-a-highly-effective-youth-leadership-program
[31] https://www.msh.org/resources/lmgnmcp-project-final-report?page=42
[32] https://www.msh.org/resources/lmgnmcp-project-final-report
[33] https://www.msh.org/resources/fighting-malaria-with-skilled-leadership?page=42
[34] https://www.msh.org/resources/fighting-malaria-with-skilled-leadership
[35] https://www.msh.org/resources/the-added-value-of-long-term-technical-assistance-to-national-malaria-control-programs?page=42
[36] https://www.msh.org/resources/the-added-value-of-long-term-technical-assistance-to-national-malaria-control-programs
[37] https://www.msh.org/resources/long-term-technical-assistance-advisors?page=42
[38] https://www.msh.org/resources/long-term-technical-assistance-advisors
[39] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf
[40] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=41
[41] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=38
[42] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=39
[43] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=40
[44] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=43
[45] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=44
[46] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=45
[47] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=46
[48] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=57